FDA Approves Nasal Influenza Vaccine For Younger Children

Armen Hareyan's picture
Advertisement

Nasal Influenza Vaccine

Advertisement

FDA approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.

Approval for the vaccine, which contains a weakened form of the live virus and is sprayed in the nose, was previously limited to healthy children 5 years of age and older and to adults up to age 49.

Advertisement